SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
1-Year Return
18.23%
This Quarter Return
-13.21%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$624M
AUM Growth
-$24.3M
(-3.7%)
Cap. Flow
+$54.8M
Cap. Flow
% of AUM
8.77%
Top 10 Holdings %
Top 10 Hldgs %
44.27%
Holding
87
New
22
Increased
22
Reduced
22
Closed
15
Top Buys
| 1 |
The Beauty Health Co
SKIN
|
$39.2M |
| 2 |
Organogenesis Holdings
ORGO
|
$13.4M |
| 3 |
AnaptysBio
ANAB
|
$13.1M |
| 4 |
CVS Health
CVS
|
$11.8M |
| 5 |
Tandem Diabetes Care
TNDM
|
$10.9M |
Top Sells
| 1 |
Illumina
ILMN
|
$21.8M |
| 2 |
OraSure Technologies
OSUR
|
$20.7M |
| 3 |
Hologic
HOLX
|
$17.3M |
| 4 |
Smith & Nephew
SNN
|
$12.3M |
| 5 |
Lantheus
LNTH
|
$8.13M |
Sector Composition
| 1 | Healthcare | 89.55% |
| 2 | Consumer Staples | 6.75% |
| 3 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Liquidia Corp
LQDA
$2.48B
| – | – |
-293,485
| Closed | -$2.11M |
|
77
NeoGenomics
NEO
$1.04B
| – | – |
-460,000
| Closed | -$5.59M |
|
|
78
OraSure Technologies
OSUR
$230M
| – | – |
-3,055,193
| Closed | -$20.7M |
|
79
Pacira BioSciences
PCRX
$1.2B
| – | – |
-22,250
| Closed | -$1.7M |
|
|
80
Smith & Nephew
SNN
$16.4B
| – | – |
-385,000
| Closed | -$12.3M |
|
81
10x Genomics
TXG
$1.69B
| – | – |
-106,139
| Closed | -$8.07M |
|
82
SPDR S&P Biotech ETF
XBI
$5.28B
| – | – |
0
| – | – |
|
|
TVRD
83
Tvardi Therapeutics, Inc. Common Stock
TVRD
$285M
| – | – |
-4,422
| Closed | -$1.93M |
|
|
ARYD
84
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| – | – |
-300,000
| Closed | -$2.94M |
|
|
OLK
85
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| – | – |
-53,961
| Closed | -$953K |
|
|
SIEN
86
DELISTED
Sientra, Inc.
SIEN
| – | – |
-164,134
| Closed | -$3.64M |
|